Eyes on GLP-1 receptor agonists
Glucagon-like peptide-1 (GLP-1) receptor agonists, such tirzepatide and semaglutide, have evolved from specialised diabetes treatments to household brands in recent years. The UK's approach to obesity and type 2 diabetes has changed as a result of its powerful effects on appetite suppression, weight loss, and glycaemic management, with prescriptions ...
openaire +1 more source
GLP-1 Receptor Agonists for Treating Alcohol Use Disorder: A Critical Review. [PDF]
Woo S +6 more
europepmc +1 more source
The Effect of GLP-1 Receptor Agonists on Epilepsy: No Appetite for Seizures. [PDF]
Karakis I.
europepmc +1 more source
GLP-1 Receptor Agonists in Brazil: Landscape of Consumption, Safety and Regulation. [PDF]
Hurtado RL +3 more
europepmc +1 more source
The Potential Indirect Impact of GLP-1 Receptor Agonists in the Management of Fibromyalgia. [PDF]
Quodling N +3 more
europepmc +1 more source
Interpreting Pregnancy Risk After GLP-1 Receptor Agonists Discontinuation. [PDF]
Scairati R, Newman C, Dunne FP, Colao A.
europepmc +1 more source
The promise of GLP-1 receptor agonists for neurodegenerative diseases. [PDF]
Athauda D +4 more
europepmc +1 more source
Effects of GLP-1 Receptor Agonists on Muscle Mass, Strength, and Quality in MASLD: A Systematic Review. [PDF]
Iorra F +5 more
europepmc +1 more source
The emerging implications of GLP-1 receptor agonists in radiation therapy. [PDF]
Reinicke T, Dilworth JT.
europepmc +1 more source
GLP-1 Receptor Agonists at the Crossroads of Circadian Biology, Sleep, and Metabolic Disease. [PDF]
Gandhi A +4 more
europepmc +1 more source

